DocCheck AG
XETRA:AJ91

Watchlist Manager
DocCheck AG Logo
DocCheck AG
XETRA:AJ91
Watchlist
Price: 8.25 EUR 7.84% Market Closed
Market Cap: 41.5m EUR
Have any thoughts about
DocCheck AG?
Write Note
Section:
 

Relative Value

The Relative Value of one AJ91 stock under the Base Case scenario is 8.76 EUR. Compared to the current market price of 8.25 EUR, DocCheck AG is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AJ91 Relative Value
Base Case
8.76 EUR
Undervaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
30
vs Industry
73
Median 3Y
0.8
Median 5Y
0
Industry
2.3
More Details
17.2
P/E
P/E
Price to Earnings
17.2
vs History
14
vs Industry
31
Median 3Y
9.5
Median 5Y
0
Industry
23.1
More Details
4.5
P/OCF
P/OCF
Price to OCF
4.5
vs History
33
vs Industry
46
Median 3Y
4.7
Median 5Y
0
Industry
14.2
More Details
5.9
P/FCFE
P/FCFE
Price to FCFE
5.9
vs History
23
vs Industry
35
Median 3Y
-42.7
Median 5Y
0
Industry
20.1
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
60
vs Industry
61
Median 3Y
1.6
Median 5Y
1.3
Industry
2.2
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
33
vs Industry
81
Median 3Y
0.4
Median 5Y
0
Industry
2.4
More Details
0.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.5
vs History
33
vs Industry
84
Median 3Y
0.6
Median 5Y
0
Industry
5
More Details
2.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
2.5
vs History
31
vs Industry
51
Median 3Y
2.6
Median 5Y
0
Industry
12.7
More Details
5.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.6
vs History
14
vs Industry
45
Median 3Y
4.5
Median 5Y
0
Industry
17.1
More Details
2.3
EV/OCF
EV/OCF
Enterprise Value to OCF
2.3
vs History
33
vs Industry
51
Median 3Y
2.4
Median 5Y
0
Industry
14
More Details
2.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
2.7
vs History
23
vs Industry
40
Median 3Y
-87.3
Median 5Y
0
Industry
18
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
61
vs Industry
73
Median 3Y
1.1
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

AJ91 Competitors Multiples
DocCheck AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
DocCheck AG
XETRA:AJ91
41.9m EUR 0.8 17.2 2.5 5.6
US
Veeva Systems Inc
NYSE:VEEV
35.3B USD 13.3 52.9 44.6 47.3
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.1B AUD 157.1 315.6 220.8 220.8
US
Doximity Inc
NYSE:DOCS
10.9B USD 21.1 62.5 47.5 49.9
US
Waystar Holding Corp
NASDAQ:WAY
6.5B USD 7.2 -123.5 25.2 70.2
JP
M3 Inc
TSE:2413
934B JPY 3.8 23.9 11.8 13.8
US
Inspire Medical Systems Inc
NYSE:INSP
5.6B USD 7.4 168.9 281.3 383.1
SE
Sectra AB
STO:SECT B
53.2B SEK 29.4 118.9 -71.1 -71.1
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -293.9 238.8 3 823.9
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16B CNY 5 44.5 32 32
P/E Multiple
Earnings Growth P/E to Growth
DE
DocCheck AG
XETRA:AJ91
Average P/E: 95.3
17.2
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
52.9
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
315.6
131%
2.4
US
Doximity Inc
NYSE:DOCS
62.5
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -123.5 N/A N/A
JP
M3 Inc
TSE:2413
23.9
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
168.9
N/A N/A
SE
Sectra AB
STO:SECT B
118.9
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -293.9 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
44.5
142%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
DocCheck AG
XETRA:AJ91
Average EV/EBITDA: 92.7
2.5
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
44.6
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
220.8
130%
1.7
US
Doximity Inc
NYSE:DOCS
47.5
92%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
25.2
N/A N/A
JP
M3 Inc
TSE:2413
11.8
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
281.3
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.1 N/A N/A
US
V
Vocera Communications Inc
F:V00
238.8
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32
143%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
DocCheck AG
XETRA:AJ91
Average EV/EBIT: 469
5.6
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
47.3
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
220.8
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.9
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
70.2
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
383.1
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.1 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 823.9
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32
123%
0.3

See Also

Summary
AJ91 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AJ91 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AJ91 stock valuation using valuation multiples.
Wall Street Estimates
AJ91 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AJ91 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.